Follow Us:
Thursday, May 19, 2022

Prabha Raghavan


Bharat Biotech nixes Covaxin supply pact with Precisa in Brazil
Sat, Jul 24, 2021

It is unclear at this stage whether the Hyderabad-based vaccine maker’s decision to terminate its November 24 contract with Precisa Medicamentos and Envixia Pharmaceuticals is a result of the controversy.

Sputnik too in Serum stable, plans 300 million doses a year
Wed, Jul 14, 2021

Russia's Sputnik V vaccine, developed by Gamaleya National Research Institute of Epidemiology and Microbiology in Moscow, was granted emergency use authorisation in India in May.

PLI schemes evoke mixed response: IT, mobile steal a march on other sectors
Mon, Jul 12, 2021

The government had to, for instance, re-open applications for its PLI scheme for medical devices due to certain issues faced in filling up the 28 slots the first time around.

Sanofi, GSK get nod for first global clinical trial with Indian population
Fri, Jul 09, 2021

Subject to “subsequent approvals”, enrollment of participants in the country “should soon begin”, said Annapurna Das, Country Head, Sanofi Pasteur India.

Zydus Cadila seeks nod for world’s first DNA Covid vaccine
Fri, Jul 02, 2021

If approved by the regulator, ZyCov-D will be the world's first DNA vaccine against infection with SARS-CoV-2.

Explained: How Zydus Cadila’s ZyCov-D vaccine for Covid-19 works, and how it is different
Fri, Aug 20, 2021

Zydus Cadila ZyCov-D vaccine: ZyCov-D is a “plasmid DNA” vaccine — or a vaccine that uses a genetically engineered, non-replicating version of a type of DNA molecule known as a 'plasmid'.

Government gives Moderna emergency use nod, may first come in only as donations
Wed, Jun 30, 2021

While the government said details on the quantity of doses to be imported to India by Cipla are still under consideration, The Indian Express has learnt that the vaccine is initially expected to be provided to India in limited quantities — as donations by the US drug maker.

Explained: How to link your passport with Covid-19 vaccine certificate
Wed, Jul 21, 2021

If you are traveling out of India to study, for a job or for the Tokyo Olympic games, it is likely that you may be asked for a Covid-19 vaccine certificate linked to your passport.

Covaxin Phase 3 data in: Efficacy 77.8% against symptomatic Covid
Wed, Jun 23, 2021

The results of the phase 3 trials come a day before the Hyderabad company’s scheduled meeting with the World Health Organization (WHO), where it is expected to submit its proposal for an Emergency Use Listing of the vaccine.

Explained: Monoclonal antibodies and Covid-19
Sun, Jun 27, 2021

Trials in the UK have found a monoclonal antibody cocktail effective in some patients with severe Covid-19. What is this treatment, how does it compare with plasma therapy, and how much promise does it hold?

Drones for vaccines: ICMR seeks bids, Telangana explores ‘Medicines from Sky’
Tue, Jun 15, 2021

Companies with logistics experience including Flipkart and Dunzo have announced their consortia under Telangana’s drone delivery scheme to develop and execute drone deliveries there.

SII-partner Novavax reports 90% efficacy, says focused first on developing countries
Tue, Jun 15, 2021

The Maryland-headquartered company said its vaccine had demonstrated 100 per cent protection in late-stage trials against moderate and severe disease caused by SARS-CoV-2 — a boost for the prospects of its Indian version, Covovax.

Vaccines for children: Plan to cover 80% over 12; Covaxin pegged to lead supply
Mon, Jun 14, 2021

Going by the 80 per cent coverage strategy, the government would have to plan for enough vaccines to cover 104 million children to effectively protect this cohort.

No emergency use, US FDA asks Bharat Biotech to obtain full approval
Sat, Jun 12, 2021

Ocugen, Bharat Biotech’s Covaxin partner in the US, “will no longer pursue an Emergency Use Authorization” of the vaccine in that country, the American clinical stage biopharmaceutical company told Nasdaq on Thursday.

Post reports of CoWin leak, IT Min asks CERT-In to probe
Sat, Jun 12, 2021

Sources at the IT Ministry said though the issue had been handled for now, CERT-In, with help of other domestic and global cybersecurity experts, was checking the entire CoWin platform once again to ensure there were no vulnerabilities.

Explained: What denial of US approval means for Covaxin, and students going there
Thu, Jun 17, 2021

The United States has decided not to give emergency use authorisation (EUA) to Bharat Biotech's Covid-19 vaccine, Covaxin. Does this mean there is something wrong with the vaccine?

Centre may renegotiate vaccine prices with SII and Bharat Biotech
Thu, Jun 10, 2021

When the Centre began vaccination in January, it procured 11 million doses of Covishield at Rs 200 each excluding taxes, and about 5.5 million doses of Covaxin at Rs 206 each excluding taxes. However, the prices were later negotiated downwards to Rs 150 per dose.

Explained: The merits and concerns of mixing Covid-19 vaccines
Mon, Jun 14, 2021

India is considering whether people can be given a mix of different Covid-19 vaccine doses. What can be the merits of such a programme, and what are the concerns? Which other countries are trying this?

Upfront payment a roadblock for vaccine availability, small hospitals lag behind
Tue, Jun 08, 2021

With smaller hospitals in non-metros facing difficulties procuring vaccines, AHPI has facilitated efforts to negotiate with vaccine makers on behalf of some of its members.

Explained: How is Biological E’s Corbevax different?
Thu, Jun 10, 2021

India has placed an advance order for 300 million doses of Corbevax. How does this Covid-19 vaccine work, and how does it differ from others? What could the order mean for India’s vaccination programme?

Substantial number of vaccine doses for India: US coordinator
Sat, Jun 05, 2021

The US will allocate doses to India based on factors such as the country’s vaccination plans, State Department Coordinator for Global Covid-19 Response Gayle E Smith said.

SII receives ‘preliminary’ permission to make test batches of Sputnik V vaccine
Sat, Jun 05, 2021

The company on Friday received Drug Controller General of India Dr V G Somani's permission to manufacture batches of Sputnik V “for test and analysis”, a source close to the development told The Indian Express on condition of anonymity.

‘At-risk’ policy change: Govt puts money on new-platform Covid-19 vaccine
Tue, Jun 08, 2021

It is significant that the government has put its money on a novel platform for a Covid-19 vaccine that is yet to receive regulatory approval.

Pfizer, Cipla demands pending, DCGI relaxes norms for clearing vaccines
Wed, Jun 02, 2021

The move, which would make it easier for companies to bring their vaccines to India, follows similar demands raised by, among others, Pfizer and Cipla during negotiations to supply imported vaccines to the country.

Tests on mixed vaccines may start in a few weeks
Mon, May 31, 2021

The testing may be carried out both using vaccines that are currently available in the country, and those that are in the pipeline.